4.3 Article

Primary Biliary Cholangitis Pathophysiology

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Genetics & Heredity

The Genetics of Primary Biliary Cholangitis: A GWAS and Post-GWAS Update

Yuki Hitomi et al.

Summary: Primary biliary cholangitis (PBC) is a chronic liver disease caused by autoimmune reactions leading to the destruction of small intrahepatic bile ducts. Genetic factors play a significant role in the development of PBC, with approximately 70 susceptibility gene loci identified through genome-wide association studies. However, the specific molecular mechanisms underlying these susceptibility loci and their impact on PBC pathogenesis remain unclear. This study provides an overview of current research on the genetic factors of PBC and discusses potential mechanisms, focusing on four major disease pathways identified through gene set analyses.
Article Immunology

Gut microbial profile of treatment-naive patients with primary biliary cholangitis

Yi-jun Zhou et al.

Summary: The gut microbiota of PBC patients from Zhejiang Province showed lower diversity and specific alterations compared to healthy controls. Six specific genera were identified as optimal biomarkers for the diagnosis of PBC. The changes in gut microbiota were associated with lipid metabolism and biosynthesis of secondary metabolites.

FRONTIERS IN IMMUNOLOGY (2023)

Article Gastroenterology & Hepatology

Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis

Laura Martinez-Gili et al.

Summary: A study on patients with primary biliary cholangitis (PBC) showed that there is variation in response to ursodeoxycholic acid (UDCA) treatment. Responders exhibited high levels of secondary and tertiary bile acids, while non-responders had lower urinary bile acid levels and higher levels of 12-dehydrocholic acid. Additionally, non-responders showed lower gut microbiota diversity and lower capacity for bile acid deconjugation.

GUT MICROBES (2023)

Review Pharmacology & Pharmacy

Seladelpar: an investigational drug for the treatment of early-stage primary biliary cholangitis (PBC)

Aaron Wetten et al.

Summary: This article summarizes the use of generic fibrates as add-in therapy for PBC and evaluates the clinical trial data of seladelpar in terms of liver biochemistry, symptomology, and safety. Results show that seladelpar leads to marked improvement in liver biochemistry and symptoms, and safety concerns have been addressed. Compared to existing off-label fibrates, seladelpar has the potential to be an attractive second-line agent in PBC.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)

Article Gastroenterology & Hepatology

Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome

Cumali Efe et al.

Summary: This study demonstrates that EHAIDs are frequently diagnosed in patients with PBC, and their presence may influence the clinical presentation of PBC but has no impact on the outcome of PBC.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA

Jorn M. Schattenberg et al.

Summary: Elafibranor demonstrated good efficacy and safety in patients with PBC who had an incomplete response to ursodeoxycholic acid, significantly reducing levels of ALP and improving other disease activity markers.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

Rosanna Asselta et al.

Summary: This study is the first comprehensive investigation of the chrX contribution to the genetics of an autoimmune liver disease, revealing a novel genome-wide significant locus related to PBC.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis

Jessica Katharine Dyson et al.

Summary: This study investigates the potential environmental contributors to autoimmune liver diseases (AILD) such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). Significant spatial clustering of PBC and PSC patients was observed, with distinct risk profiles and associations with different environmental factors and socio-economic statuses identified. This suggests different triggers and alternative pathways determine the phenotypic expression of autoimmunity in the affected population.

JHEP REPORTS (2021)

Article Medicine, General & Internal

Primary biliary cholangitis

Ana Lleo et al.

LANCET (2020)

Review Immunology

Sex-related factors in autoimmune liver diseases

Dorothee Schwinge et al.

SEMINARS IN IMMUNOPATHOLOGY (2019)

Review Immunology

The microbiome and autoimmunity: a paradigm from the gut-liver axis

Bo Li et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2018)

Article Gastroenterology & Hepatology

Persistent reduction of mucosal-associated invariant T cells in primary biliary cholangitis

Toru Setsu et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Immunology

Dysregulation of Circulating Tfr/Tfh Ratio in Primary biliary cholangitis

J. Zheng et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2017)

Review Medicine, Research & Experimental

Microbiota, cirrhosis, and the emerging oral-gut-liver axis

Chathur Acharya et al.

JCI INSIGHT (2017)

Article Gastroenterology & Hepatology

Soluble Adenylyl Cyclase Regulates Bile Salt-Induced Apoptosis in Human Cholangiocytes

Jung-Chin Chang et al.

HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1

Hannah C. Jeffery et al.

JOURNAL OF HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Natural Killer Cells Regulate T Cell Immune Responses in Primary Biliary Cirrhosis

Shinji Shimoda et al.

HEPATOLOGY (2015)

Review Gastroenterology & Hepatology

New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond

Ulrich Beuers et al.

JOURNAL OF HEPATOLOGY (2015)

Review Gastroenterology & Hepatology

Intestinal permeability - a new target for disease prevention and therapy

Stephan C. Bischoff et al.

BMC GASTROENTEROLOGY (2014)

Article Multidisciplinary Sciences

Crystal structures of human soluble adenylyl cyclase reveal mechanisms of catalysis and of its activation through bicarbonate

Silke Kleinboelting et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Review Gastroenterology & Hepatology

Apotopes and innate immune system: Novel players in the primary biliary cirrhosis scenario

Ana Lleo et al.

DIGESTIVE AND LIVER DISEASE (2013)

Article Immunology

Gender Bias in Autoimmunity Is Influenced by Microbiota

Leonid Yurkovetskiy et al.

IMMUNITY (2013)

Article Multidisciplinary Sciences

Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity

Janet G. M. Markle et al.

SCIENCE (2013)

Article Biochemistry & Molecular Biology

Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism

Mi Young Lee et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2012)

Review Biochemistry & Molecular Biology

Nuclear receptor PXR, transcriptional circuits and metabolic relevance

Chibueze A. Ihunnah et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)

Article Gastroenterology & Hepatology

Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis

Christophe Corpechot et al.

JOURNAL OF HEPATOLOGY (2010)

Review Medicine, Research & Experimental

Innate Immunity and Primary Biliary Cirrhosis

Carlo Selmi et al.

CURRENT MOLECULAR MEDICINE (2009)

Article Gastroenterology & Hepatology

Apotopes and the Biliary Specificity of Primary Biliary Cirrhosis

Ana Lleo et al.

HEPATOLOGY (2009)

Article Immunology

Primary biliary cirrhosis is associated with altered hepatic microRNA expression

Kerstien A. Padgett et al.

JOURNAL OF AUTOIMMUNITY (2009)

Review Gastroenterology & Hepatology

Interpreting serological tests in diagnosing autolmmune liver diseases

Pietro Invernizzi et al.

SEMINARS IN LIVER DISEASE (2007)

Article Multidisciplinary Sciences

Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor

T Inagaki et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Review Gastroenterology & Hepatology

Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms

JYL Chiang

JOURNAL OF HEPATOLOGY (2004)

Article Biochemistry & Molecular Biology

Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity

H Kitada et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Biochemistry & Molecular Biology

Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor

M Ananthanarayanan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Multidisciplinary Sciences

The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity

JL Staudinger et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Review Chemistry, Medicinal

The PPARs: From orphan receptors to drug discovery

TM Willson et al.

JOURNAL OF MEDICINAL CHEMISTRY (2000)